Skip to main content

Translational Medicine: Cancer, 2 Volume Set

Translational Medicine: Cancer, 2 Volume Set

Robert A. Meyers (Editor)

ISBN: 978-3-527-68187-7

May 2016, Wiley-Blackwell

940 pages

$376.99

Description

The first complete overview of progress in the field.
The two volumes contain selected articles from the prestigious online Encyclopedia of Molecular Cell Biology and Molecular Medicine, fully updated and enriched with numerous new contributions from many eminent scientists.
Divided into three parts, the first gives a thorough introduction to cancer biology, while Part Two covers therapeutic approaches for all major forms of cancer, and the third part deals with cancer diagnostics.
The result is a one-stop resource for advanced students, postdoctoral researchers and start-up companies.
VOLUME 1

PART 1: CANCER BIOLOGY

Cancer of the Prostate: Molecular Genetics

Prostate Tissue Stem Cells and Prostate Cancer Progression

Cancer Stem Cells

Chromatin Remodeling in Carcinoma Cells

Genetics and Molecular Biology of Lung Cancer

Growth Factors and Oncogenes in Gastrointestinal Cancers

Immunology of Cancer

Immunosuppressive Factors in Cancer

Intracellular Signaling in Cancer

Liver Cancer, Molecular Biology of

Mechanisms of Cancer Progression

The role of stem cell niches in self-renewal, aging, and malignancy

Mutagenesis, Malignancy and Genome Instability

Retinal Blastoma

VOLUME 2

PART 2: CANCER THERAPIES

Molecular Oncology

Theoretical Foundations of Cancer Chemotherapy

Immunotoxins and Recombinant Immunotoxins in Cancer Therapy

Pharmaco-Epigenomics to Improve Cancer Therapies

Stem cells and colon cancer

Targeted Therapy: Genomic Approaches

Telomerase Inhibitors in Cancer Therapies

Therapeutics against cancer stem cells

PART 3: MOLECULAR DIAGNOSTICS AND IMAGING

Circulating Plasma DNA Analysis in Personalized Cancer Evaluation

Circulating Tumor cells (CTCs) in Blood in Cancer Stage Evaluation

DNA in Neoplastic Disease Diagnosis

Personalized Oncology Through DNA sequencing

Proteomic Cancer Biomarkers